BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Tourkochristou E, Mouzaki A, Triantos C. Unveiling the biological role of sphingosine-1-phosphate receptor modulators in inflammatory bowel diseases. World J Gastroenterol 2023; 29(1): 110-125 [PMID: 36683721 DOI: 10.3748/wjg.v29.i1.110]
URL: https://www.wjgnet.com/1007-9327/full/v29/i1/110.htm
Number Citing Articles
1
Juan Liu, Yali Chen, Luke O’Neill. Phospholipid metabolism in innate immunity and inflammation: from basic to clinicImmunity & Inflammation 2025; 1(1) doi: 10.1007/s44466-025-00001-5
2
Piotr Minkiewicz, Małgorzata Darewicz, Anna Iwaniak. In Silico Analysis of Individual Fractions of Bovine Casein as Precursors of Bioactive Peptides—Influence of Post-Translational ModificationsApplied Sciences 2023; 13(14): 8091 doi: 10.3390/app13148091
3
L. G. Rabinowitz, A. Gade, T. Deyhim, J. D. Feuerstein. Safety and use of IBD therapies during pregnancy and lactationExpert Review of Gastroenterology & Hepatology 2026; : 1 doi: 10.1080/17474124.2026.2615447
4
Sara Massironi, Federica Furfaro, Sarah Bencardino, Mariangela Allocca, Silvio Danese. Immunity in digestive diseases: new drugs for inflammatory bowel disease treatment—insights from Phase II and III trialsJournal of Gastroenterology 2024; 59(9): 761 doi: 10.1007/s00535-024-02130-x
5
Priyadarshan Singh, Paramjit Saini, Pravin P Kalyankar, Kamaljit R Kailey, Rohan Chauhan, Anupamdeep K Pannu, Navpreet Singh, Ketan Garg. Drug Management of Inflammatory Bowel Disease (IBD): A Narrative ReviewCureus 2025;  doi: 10.7759/cureus.95635
6
Amy Zhuang-Yan, Matt Shirley. Etrasimod in moderately to severely active ulcerative colitis: a profile of its use in the EUDrugs & Therapy Perspectives 2025; 41(8): 327 doi: 10.1007/s40267-025-01176-y
7
Xiaona Yang, Hong Guo, Min Zou. Inflammatory bowel diseases: pathological mechanisms and therapeutic perspectivesMolecular Biomedicine 2026; 7(1) doi: 10.1186/s43556-025-00395-z
8
AHMAD SHAHIR MOHAMAD NAZRI, NAZIHAH MOHD YUNUS, MARAHAINI MUSA. The genetics of pediatric inflammatory bowel disease: Towards precision medicineBIOCELL 2025; 49(1): 149 doi: 10.32604/biocell.2024.057352
9
Waqas Waqas, Ye Yuan, Yongcheng Xue, Liyun Wang, Yongyi Chen, Jiajia Zhang, Tariq Dildar, Mhd Ikhwanuddin, Hongyu Ma. Lipidomics: An emerging tool in aquatic toxicology researchJournal of Hazardous Materials 2025; 494: 138777 doi: 10.1016/j.jhazmat.2025.138777
10
Han-Rui Zhang, Gu-Quan Ma, He-Qun Lv, Yao-Ting Feng, Yong-Jun Peng. Electroacupuncture Alleviates Cerebral Ischemia-reperfusion Injury by Regulating the S1PR2/TLR4/NLRP3 Signaling Pathway via m6A Methylation of lncRNA H19Current Neurovascular Research 2024; 21(1): 64 doi: 10.2174/0115672026294183240207115956
11
Shi-Yan Zhang. Navigating new horizons in inflammatory bowel disease: Integrative approaches and innovationsWorld Journal of Gastroenterology 2024; 30(41): 4411-4416 doi: 10.3748/wjg.v30.i41.4411
12
Valentina Vellecco, Erika Esposito, Chiara Indolfi, Anella Saviano, Elisabetta Panza, Mariarosaria Bucci, Vincenzo Brancaleone, Giuseppe Cirino, Roberta d'Emmanuele di Villa Bianca, Raffaella Sorrentino, Emma Mitidieri. Biphasic inflammatory response induced by intra-plantar injection of L-cysteine: Role of CBS-derived H2S and S1P/NO signalingBiomedicine & Pharmacotherapy 2023; 167: 115536 doi: 10.1016/j.biopha.2023.115536
13
Pooja Kushwaha, Rahila Qureshi, Nooruddin Khan, Sangita Mukhopadhyay. Revolutionizing IBD therapy: Insights into contemporary treatment strategiesInternational Reviews of Immunology 2026; 45(1): 1 doi: 10.1080/08830185.2025.2563522
14
Aaron Hass, Laetitia Amar, Robert Battat. S1PR Modulators in the Management of Ulcerative Colitis: Considerations for PracticeCanadian IBD Today 2024;  doi: 10.58931/cibdt.2024.2333
15
Naim Asyraf Rosli, Anis Rageh Al-Maleki, Mun Fai Loke, Sun Tee Tay, Mohd Salleh Rofiee, Lay Kek Teh, Mohd Zaki Salleh, Jamuna Vadivelu, Bashir Sajo Mienda. Exposure of Helicobacter pylori to clarithromycin in vitro resulting in the development of resistance and triggers metabolic reprogramming associated with virulence and pathogenicityPLOS ONE 2024; 19(3): e0298434 doi: 10.1371/journal.pone.0298434
16
Linyuan Wang, Xiaowen Zhang, Chunyan Ma, Nan Wu. 1-Phosphate receptor agonists: A promising therapeutic avenue for ischemia-reperfusion injury managementInternational Immunopharmacology 2024; 131: 111835 doi: 10.1016/j.intimp.2024.111835